(Q70523434)

English

Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types III, IV, and V familial hyperlipoproteinemia

scientific article published on 01 July 1971

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types III, IV, and V familial hyperlipoproteinemia (English)

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Charles J Glueck

1

object named as

C. J. Glueck

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5090133

12 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5090133

12 December 2023

publication date

1 July 1971

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

number of pages

12

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:0026049571900837?httpAccept=text/xml

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

https://api.elsevier.com/content/article/PII:0026049571900837?httpAccept=text/plain

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

691-702

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Metabolic and Serum Lipid Effects of Methylandrostane and Methylandrostene Pyrazoles*

1

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Practical significance of serum triglycerides and radioactive fat tolerance. Their relation to current therapy for hypercholesterolemia

3

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Effect of oxandrolone on plasma lipids and lipoproteins of patients with disorders of lipid metabolism

4

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Idiopathic hyperglyceridaemia treated with methyl testosterone and methandienone

5

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia

6

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

8

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders

9

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

10

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

11

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

12

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Lipoproteins in primary biliary cirrhosis

13

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

The effect of diet and thyroxin on plasma lipids in myxedema

15

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

STUDIES OF ALCOHOLIC HYPERLIPEMIA AND ITS MECHANISM

18

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

A New Mechanism of Exogenous Hyperglyceridemia

19

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer

23

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

A further characterization of lipoprotein lipase

27

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Effect of a C17-alkylated steroid methandrostenolone on plasma lipids of normal subjects

29

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Metabolic changes induced in elderly patients with an anabolic steroid (oxandrolone)

30

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

THE EFFECT OF ANABOLIC STEROIDS ON BLOOD SUGAR AND PLASMA INSULIN LEVELS IN MAN

31

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

EFFECT OF CONJUGATED EQUINE ESTROGENS ON SERUM LIPIDS AND THE CLOTTING MECHANISM

33

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

The Activity of the Lipoprotein Lipase and Estrogens

34

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Studies on the Mechanism of Increased Plasma Triglyceride Levels Induced by Oral Contraceptives

35

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

The significance of changes in tissue clearing-factor lipase activity in relation to the lipaemia of pregnancy

36

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives

37

1 reference

10.1016/0026-0495(71)90083-7

https://api.crossref.org/works/10.1016/0026-0495(71)90083-7

12 December 2023

Identifiers

10.1016/0026-0495(71)90083-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5090133%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70523434&oldid=2028604438"